Latest articles
No of your stocks has realtime/relevant news articles that can be accessed.
Take a look into our News feed to read about recent price changes and analysis.
Sentiment statistics ?
Financial Histories
Please use our Financial history templates to chart, read and compare all 10'Q filings in depth.
Overview
STAADay performance
| STAA | |
|---|---|
| Price | 33.90 |
| Change Pct | 0.56 |
| Change Abs | 0.19 |
| Market Cap | 1.7 billion |
| Eps | 0.38 |
| Pe Ratio | 89.21 |
| Outstanding Shares | 48.8 million |
| Volume | 254971 |
| Avg Volume | 772704 |
| Industry | Medical Instruments & Supplies |
| Sector Name | Health Care |
| Country Short Name | US |
| Announcement Earnings | 2024-02-19 10:59:00+00:00 |
Dividends
There is no dividend data to display. Refer our Dividend calendar for other accurate data.
Risk Profiles
Please sign up and become a member to view all risk profiles.
Peers
HOLX
BDX
RMD
3 Login now
4 Login now
5 Login now
6 Login now
7 Login now
8 Login now
9 Login now
Focus
Use our 'Focus' approach as text-and chart based summaries of the financial standing for a company. They are solely focussing on the company's market, risks and chances.
STAA
Company descriptions
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery.